Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Familial Cancer|May 19, 2015
Psychological distress related to BRCA testing in ovarian cancer patientsMerete Bjørnslett, Alv A Dahl, Øystein Sørebø, et al.
BMC Cancer|October 9, 2012
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriersMerete Bjørnslett, Stian Knappskog, Per Eystein Lønning, et al.
British Journal of Haematology|September 15, 2005
t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigationsHege Vangstein Aamot, Merete Bjørnslett, Jan Delabie, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
Germline PTEN mutations are rare and highly penetrantCecilie F Rustad, Merete Bjørnslett, Ketil R Heimdal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2025
BRCA mutation testing and association with oncologic outcome and incidence of ovarian cancer in NorwayAlda Birgisdóttir, Tor Åge Myklebust, Merete Bjørnslett, et al.
Human Mutation|September 11, 2008
Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- statusStine A Danielsen, Guro E Lind, Merete Bjørnslett, et al.
Scientific Reports|December 7, 2021
Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancerLiv B Gansmo, Nigar Sofiyeva, Merete Bjørnslett, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 24, 2019
Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2Nair Lopes, Christian Holst Bergsland, Merete Bjørnslett, et al.
Plos One|August 1, 2017
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive diseaseJohannes Landskron, Sigrid M Kraggerud, Elisabeth Wik, et al.
BMC Cancer|February 5, 2017
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer riskLiv B Gansmo, Merete Bjørnslett, Mari Kyllesø Halle, et al.
Pageof 3